HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AAD Product Previews In Brief: Neutrogena

This article was originally published in The Rose Sheet

Executive Summary

Neutrogena: "Full-scale" launch of dermatologist detailing and sampling program for Neutrogena Healthy Skin Anti-Wrinkle facial cream coincides with AAD's San Francisco meeting, the Johnson & Johnson division said. Neutrogena plans to distribute about 750,000 Healthy Skin Anti-Wrinkle sample-sized "starter" products annually; the company's sales force visits about 5,000 dermatologists on a regular basis, the firm noted. Neutrogena also plans to advertise Healthy Skin Anti-Wrinkle facial cream, which is launching in March, in April medical journals. Neutrogena has already distributed full-sized product samples and technical background information about Healthy Skin clinical trials to "high prescribing" dermatological audiences, the company noted. To reach consumers, ads will break in March books and a TV campaign is planned, Neutrogena noted...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003901

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel